Wells Fargo & Company Legend Biotech Corp Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Legend Biotech Corp stock. As of the latest transaction made, Wells Fargo & Company holds 15,051 shares of LEGN stock, worth $852,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,051
Previous 8,199
83.57%
Holding current value
$852,037
Previous $493,000
71.2%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LEGN
# of Institutions
213Shares Held
63.8MCall Options Held
1.09MPut Options Held
525K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$620 Million0.08% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$339 Million7.45% of portfolio
-
Black Rock Inc. New York, NY5.38MShares$305 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.61MShares$148 Million0.03% of portfolio
-
Capital World Investors Los Angeles, CA2.39MShares$135 Million0.02% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $9.48B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...